TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,519,280 | -6.5% | 292,132 | -5.0% | 0.00% | -100.0% |
| Q2 2023 | $4,831,312 | +295.4% | 307,531 | +315.0% | 0.00% | – |
| Q1 2023 | $1,221,780 | +462695.5% | 74,108 | +337.4% | 0.00% | – |
| Q4 2022 | $264 | -99.9% | 16,942 | -5.5% | 0.00% | – |
| Q3 2022 | $233,000 | -2.5% | 17,936 | +5.2% | 0.00% | – |
| Q2 2022 | $239,000 | -3.6% | 17,052 | -1.6% | 0.00% | – |
| Q1 2022 | $248,000 | +4.6% | 17,331 | -0.5% | 0.00% | – |
| Q4 2021 | $237,000 | -23.8% | 17,425 | -8.4% | 0.00% | – |
| Q3 2021 | $311,000 | -21.5% | 19,021 | -19.1% | 0.00% | – |
| Q2 2021 | $396,000 | -91.8% | 23,508 | -91.1% | 0.00% | -100.0% |
| Q1 2021 | $4,818,000 | +479.8% | 263,854 | +477.9% | 0.00% | – |
| Q4 2020 | $831,000 | -76.2% | 45,661 | -76.3% | 0.00% | -100.0% |
| Q3 2020 | $3,488,000 | +56.9% | 192,280 | +55.2% | 0.00% | – |
| Q2 2020 | $2,223,000 | -19.0% | 123,922 | -31.5% | 0.00% | -100.0% |
| Q1 2020 | $2,746,000 | +156.6% | 180,883 | +233.5% | 0.00% | – |
| Q4 2019 | $1,070,000 | +147.1% | 54,237 | +115.1% | 0.00% | – |
| Q3 2019 | $433,000 | -3.8% | 25,211 | -1.8% | 0.00% | – |
| Q2 2019 | $450,000 | -13.5% | 25,661 | +0.6% | 0.00% | – |
| Q1 2019 | $520,000 | -55.3% | 25,518 | -63.1% | 0.00% | – |
| Q4 2018 | $1,163,000 | – | 69,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |